Detailed information for compound 1087394

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 353.2 | Formula: C16H14Cl2N2O3
  • H donors: 3 H acceptors: 3 LogP: 3.57 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1cc(/C=N/CCNC(=O)c2ccccc2O)c(c(c1)Cl)O
  • InChi: 1S/C16H14Cl2N2O3/c17-11-7-10(15(22)13(18)8-11)9-19-5-6-20-16(23)12-3-1-2-4-14(12)21/h1-4,7-9,21-22H,5-6H2,(H,20,23)/b19-9+
  • InChiKey: IUJSUOSUBXTLFB-DJKKODMXSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Escherichia coli 3-oxoacyl-[acyl-carrier-protein] synthase III Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium ulcerans beta-ketoacyl synthase-like protein Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium falciparum beta-ketoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium berghei apicoplast beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Chlamydia trachomatis oxoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) Get druggable targets OG5_129509 All targets in OG5_129509
Neospora caninum 3-oxoacyl-(acyl-carrier-protein) synthase III family protein, putative Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium knowlesi beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Conserved hypothetical protein 3-oxoacyl-[acyl-carrier-protein] synthase III 317 aa 265 aa 26.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi F/Y-rich N-terminus family protein 0.0011 0.0115 0.0928
Schistosoma mansoni hypothetical protein 0.049 1 1
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.0375 0.0424
Onchocerca volvulus 0.0034 0.0608 0.5
Echinococcus multilocularis dna polymerase kappa 0.0023 0.0375 0.0303
Entamoeba histolytica fatty acid elongase, putative 0.005 0.0923 1
Echinococcus granulosus dna polymerase kappa 0.0023 0.0375 0.0303
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Giardia lamblia DINP protein human, muc B family 0.0023 0.0375 1
Brugia malayi CXXC zinc finger family protein 0.0034 0.0608 0.758
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0011 0.0118 0.0044
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0375 1
Schistosoma mansoni cpg binding protein 0.0036 0.0648 0.0648
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Leishmania major DNA polymerase eta, putative 0.0023 0.0375 1
Entamoeba histolytica fatty acid elongase, putative 0.005 0.0923 1
Echinococcus granulosus dna polymerase eta 0.0023 0.0375 0.0303
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0023 0.0375 0.0303
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0375 1
Brugia malayi hypothetical protein 0.0043 0.0787 1
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 0.7791 1
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0375 1
Schistosoma mansoni cpg binding protein 0.0036 0.0648 0.0648
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0009 0.0074 0.0074
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.0383 0.7791 1
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0383 0.7791 0.5
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0023 0.0375 1
Trypanosoma brucei unspecified product 0.0023 0.0375 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0375 1
Brugia malayi ImpB/MucB/SamB family protein 0.0023 0.0375 0.4438
Loa Loa (eye worm) histone methyltransferase 0.0011 0.0118 0.1274
Leishmania major DNA polymerase kappa, putative 0.0023 0.0375 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0227 0.55
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Entamoeba histolytica hypothetical protein 0.0043 0.0787 0.7512
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Schistosoma mansoni terminal deoxycytidyl transferase 0.0023 0.0375 0.0375
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.0375 0.0424
Schistosoma mansoni cpg binding protein 0.0034 0.0608 0.0608
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Trypanosoma cruzi DNA polymerase eta, putative 0.0023 0.0375 1
Schistosoma mansoni DNA polymerase eta 0.0023 0.0375 0.0375
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.0383 0.7791 1
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.0383 0.7791 1
Brugia malayi ImpB/MucB/SamB family protein 0.0023 0.0375 0.4438
Loa Loa (eye worm) hypothetical protein 0.0023 0.0375 0.5855
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0043 0.0787 0.0718
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0227 0.55
Toxoplasma gondii histone lysine methyltransferase SET1 0.0065 0.1242 1
Schistosoma mansoni hypothetical protein 0.0203 0.4083 0.4083
Trypanosoma brucei DNA polymerase kappa, putative 0.0016 0.0227 0.55
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0375 1
Trypanosoma brucei unspecified product 0.0016 0.0227 0.55
Trypanosoma brucei DNA polymerase eta, putative 0.0023 0.0375 1
Echinococcus multilocularis dna polymerase eta 0.0023 0.0375 0.0303
Entamoeba histolytica hypothetical protein 0.0043 0.0787 0.7512
Trichomonas vaginalis DNA polymerase eta, putative 0.0023 0.0375 1
Entamoeba histolytica fatty acid elongase, putative 0.005 0.0923 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.0034 0.0608 1
Chlamydia trachomatis oxoacyl-ACP synthase III 0.0383 0.7791 0.5
Echinococcus multilocularis cpg binding protein 0.0036 0.0648 0.0578
Schistosoma mansoni hypothetical protein 0.0203 0.4083 0.4083
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0023 0.0375 0.5855
Schistosoma mansoni transcription factor LCR-F1 0.0043 0.0787 0.0787
Schistosoma mansoni hypothetical protein 0.0043 0.0787 0.0787
Trypanosoma brucei unspecified product 0.0016 0.0227 0.55
Entamoeba histolytica fatty acid elongase, putative 0.005 0.0923 1
Echinococcus granulosus cpg binding protein 0.0036 0.0648 0.0578
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0023 0.0375 1
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0375 1
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0023 0.0375 0.0375
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0073 0.1403 0.1403
Echinococcus granulosus geminin 0.0203 0.4083 0.4039
Echinococcus multilocularis dnaJ subfamily B 0.049 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0375 1
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0023 0.0375 0.0303
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Schistosoma mansoni DNA polymerase IV / kappa 0.0007 0.0046 0.0046
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 0.7791 1
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0011 0.0118 0.0044
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Entamoeba histolytica hypothetical protein 0.0043 0.0787 0.7512
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Entamoeba histolytica hypothetical protein 0.0043 0.0787 0.7512
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0043 0.0787 0.0718
Echinococcus multilocularis geminin 0.0203 0.4083 0.4039
Entamoeba histolytica fatty acid elongase, putative 0.005 0.0923 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0375 1
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.0383 0.7791 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2.5 ug ml-1 Inhibition of Escherichia coli Beta-ketoacyl-ACP synthase III expressed in Escherichia coli BL21 (DE3) by liquid scintillation counting ChEMBL. 19884012
MIC (functional) = 1.56 ug ml-1 Antimicrobial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay ChEMBL. 19884012

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.